title: Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
authors.affiliation: Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori [corrected]
authors.forename: Gianni
authors.initials: G
authors.lastname: Bonadonna
authors.forename: Pinuccia
authors.initials: P
authors.lastname: Valagussa
authors.forename: Umberto
authors.initials: U
authors.lastname: Veronesi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage
chemical_list: D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate